Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 450 results for "celgene corporation headquarters"

Medidata Solutions Clinical Cloud Gets Picked by Celgene
Zacks.com

Medidata Solutions Clinical Cloud Gets Picked by Celgene

Headquartered in New York, Medidata Solutions Inc. MDSO recently announced that Celgene Corporation CELG has adopted Medidata Clinical Cloud for using its suite of strategic monitoring tools and data analytics solutions. Over the past one year, ... Yahoo! Finance, 2 days ago
Freshnews.com

Celgene Corporation Announces Preliminary 2016 Unaudited Results and 2017 Financial Guidance

SUMMIT, N.J.--( BUSINESS WIRE )--Celgene Corporation (NASDAQ:CELG) today provided a business update as well as its preliminary 2016 unaudited results and financial guidance for 2017 at the 35 th Annual J.P. Morgan Healthcare Conference. In 2017, ...
 Business Wire1 week ago CELGENE CORPORATION : to Announce Fourth Quarter and Full-Year 2016 Results on January 26, 2017  4 Traders2 weeks ago Celgene Corporation to Announce Fourth Quarter and Full-Year 2016 Results on January 26, 2017  TMC Net2 weeks ago Oral PDE-4 Inhibitor, OTEZLA®, Approved for the Treatment of Plaque Psoriasis and Psoriatic Arthritis in Japan  Business Wire1 month ago
[x]  

BRIEF-Acetylon Pharmaceuticals entered into an agreement to be acquired by Celgene Corporation

n"Dec 2 Acetylon Pharmaceuticals * Acetylon Pharmaceuticals -Regenacy Pharmaceuticals to be launched by Acetylon Pharmaceuticals and Celgene Corporation agrees to complete acquisition of acetylon* Acetylon Pharmaceuticals - entered into an ...
 Reuters UK1 month ago Acetylon Pharmaceuticals entered into an agreement to be acquired by Celgene Corporation  Pharma Focus Asia1 month ago
Freshnews.com

Celgene Corporation to Present at the 35th Annual J.P. Morgan Healthcare Conference

During the 35th Annual J.P. Morgan Healthcare Conference on January 9, 2017 at 10:30 a.m. ET, Celgene Corporation (NASDAQ:CELG) will present a business update on the Company in addition to unaudited 2016 financial results and an updated financial ...
 Stockwatch2 weeks ago CELGENE CORPORATION : to Present at the 35th Annual J.P. Morgan Healthcare Conference  4 Traders2 weeks ago
[x]  
Ariva.de

Juno??? And Celgene???s Investigational Drug JCAR017 Granted Breakthrough Therapy Designation From FDA And Priority Medicines Eligibility From EMAFor Relapsed/Refractory Diffuse Large B-Cell Lymphoma

SEATTLE & SUMMIT, N.J.--( BUSINESS WIRE )--Juno Therapeutics, Inc. (NASDAQ: JUNO) and Celgene Corporation (NASDAQ: CELG), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
 BioSpace1 month ago Juno Therapeutics and Celgene Corporation's Investigational Drug JCAR017 Granted Breakthrough Therapy Designation from FDA and Priority Medicines Eligibility from EMA for Relapsed/Refractory Diffuse Large B-cell Lymphoma  Enhanced Online News1 month ago Juno Therapeutics' and Celgene Corporation's Investigational Drug JCAR017 Granted Breakthrough Therapy Designation from FDA and Priority Medicines Eligibility from EMA for Relapsed/Refractory Diffuse Large B-cell Lymphoma  Benzinga.com1 month ago CELGENE : Juno Therapeutics' and Celgene Corporation's Investigational Drug JCAR017 Granted Breakthrough Therapy Designation from FDA and Priority Medicines Eligibility from EMA for Relapsed/Refractory Diffuse Large B-cell Lymphoma  4 Traders1 month ago
[x]  

Acceleron and Celgene Announce Preliminary Results from an Investigator Initiated Phase 2 Study of Sotatercept in Myelofibrosis at the 58th Annual Meeting of the American Society of Hematology

CAMBRIDGE, Mass. & SUMMIT, N.J.--(Business Wire)--Acceleron Pharma Inc. (NASDAQ:XLRN) and Celgene Corporation (NASDAQ:CELG), today announced preliminary results from an ongoing investigator initiated Phase 2 study with investigational drug ...
 Digital Journal1 month ago Acceleron and Celgene Announce Updated Results from Ongoing Phase 2 Studies of Luspatercept in Myelodysplastic Syndromes at the 58th Annual Meeting of the American Society of Hematology  Yahoo! Singapore1 month ago Acceleron Pharma And Celgene Announce Preliminary Results From An Investigator Initiated Phase 2 Study Of Sotatercept In Myelofibrosis At The 58th Annual Meeting Of American Society of Hematology  BioSpace1 month ago
[x]  

Celgene Corporation, Dana-Farber Cancer Institute and University of Arkansas for Medical Sciences Establish the Myeloma Genome Project

Project will create the largest dataset of molecular profiling for patients with multiple myeloma leading to tests that could improve diagnosis, prognosis and new treatments SAN DIEGO--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG), ...
 Nasdaq1 month ago Celgene Corporation :, Dana-Farber Cancer Institute and University of Arkansas for Medical Sciences Establish the Myeloma Genome Project  4 Traders1 month ago
[x]  

Regenacy Pharmaceuticals to be Launched by Acetylon Pharmaceuticals and Celgene Corporation Agrees to Complete Acquisition of Acetylon

-- Celgene secures worldwide rights to Acetylon's selective HDAC6 inhibitor programs and intellectual property in oncology, neurodegeneration, and autoimmune disease -- -- Regenacy receives exclusive, worldwide license from Celgene to Acetylon's ...
 4 Traders1 month ago
[x]  
Schaeffers Research

Stocks On the Move: Flotek Industries Inc, Sigma Designs Inc, and Celgene Corporation

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Learn more about us >> Welcome to Schaeffer's ...
 Schaeffers Research1 month ago

Oral OTEZLA®▼ (Apremilast) Receives Positive Nice Recommendation for Adults with Psoriatic Arthritis

STOCKLEY PARK, England--(Business Wire)--Celgene announced today that the National Institute for Health and Care Excellence (NICE) has issued a final appraisal determination (FAD) recommending the use of OTEZLA (apremilast) for the treatment of ...
 Digital Journal4 weeks ago Oral OTEZLA (Apremilast) Receives Positive Nice Recommendation for Adults with Psoriatic Arthritis  CPhI.cn3 weeks ago Celgene Release: Oral OTEZLA (Apremilast) Receives Positive Nice Recommendation For Adults With Psoriatic Arthritis  BioSpace4 weeks ago Oral OTEZLA®? (Apremilast) Receives Positive Nice Recommendation for Adults with Psoriatic Arthritis  Financial Buzz4 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less